• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素的抗病毒治疗潜力:最新研究进展。

Antiviral Therapeutic Potential of Curcumin: An Update.

机构信息

Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

出版信息

Molecules. 2021 Nov 19;26(22):6994. doi: 10.3390/molecules26226994.

DOI:10.3390/molecules26226994
PMID:34834089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8617637/
Abstract

The treatment of viral disease has become a medical challenge because of the increasing incidence and prevalence of human viral pathogens, as well as the lack of viable treatment alternatives, including plant-derived strategies. This review attempts to investigate the trends of research on in vitro antiviral effects of curcumin against different classes of human viral pathogens worldwide. Various electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar were searched for published English articles evaluating the anti-viral activity of curcumin. Data were then extracted and analyzed. The forty-three studies (published from 1993 to 2020) that were identified contain data for 24 different viruses. The 50% cytotoxic concentration (CC50), 50% effective/inhibitory concentration (EC50/IC50), and stimulation index (SI) parameters showed that curcumin had antiviral activity against viruses causing diseases in humans. Data presented in this review highlight the potential antiviral applications of curcumin and open new avenues for further experiments on the clinical applications of curcumin and its derivatives.

摘要

由于人类病毒病原体的发病率和患病率不断上升,以及缺乏可行的治疗替代品,包括植物衍生策略,病毒疾病的治疗已成为医学挑战。本综述试图调查全球范围内姜黄素对不同类人类病毒病原体的体外抗病毒作用的研究趋势。检索了包括 PubMed、Scopus、Web of Science 和 Google Scholar 在内的各种电子数据库,以查找评估姜黄素抗病毒活性的已发表英文文章。然后提取和分析数据。确定的 43 项研究(发表于 1993 年至 2020 年)包含了 24 种不同病毒的数据。50%细胞毒性浓度 (CC50)、50%有效/抑制浓度 (EC50/IC50) 和刺激指数 (SI) 参数表明,姜黄素对引起人类疾病的病毒具有抗病毒活性。本综述中提供的数据突出了姜黄素的潜在抗病毒应用,并为进一步研究姜黄素及其衍生物的临床应用开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa53/8617637/ea79f305ac7d/molecules-26-06994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa53/8617637/893761b0a400/molecules-26-06994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa53/8617637/ea79f305ac7d/molecules-26-06994-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa53/8617637/893761b0a400/molecules-26-06994-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa53/8617637/ea79f305ac7d/molecules-26-06994-g002.jpg

相似文献

1
Antiviral Therapeutic Potential of Curcumin: An Update.姜黄素的抗病毒治疗潜力:最新研究进展。
Molecules. 2021 Nov 19;26(22):6994. doi: 10.3390/molecules26226994.
2
Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects.草药及植物代谢产物/提取物对抗病毒病原体的药用和治疗潜力——当前认知与未来展望
Curr Drug Metab. 2018;19(3):236-263. doi: 10.2174/1389200219666180129145252.
3
Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.病毒-宿主相互作用:抗病毒病原体药物研发的新见解与进展
Curr Drug Metab. 2017;18(10):942-970. doi: 10.2174/1389200218666170925115132.
4
Curcumin as an Antiviral Agent.姜黄素作为抗病毒药物。
Viruses. 2020 Oct 31;12(11):1242. doi: 10.3390/v12111242.
5
Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review.姜黄素作为一种天然的潜在药物候选物,对抗重要的人畜共患病毒和朊病毒:叙述性综述。
Phytother Res. 2024 Jun;38(6):3080-3121. doi: 10.1002/ptr.8119. Epub 2024 Apr 12.
6
Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.药用植物抗 HIV、HSV、流感、肝炎和柯萨奇病毒的抗病毒潜力:系统评价。
Phytother Res. 2018 May;32(5):811-822. doi: 10.1002/ptr.6024. Epub 2018 Jan 22.
7
Therapeutic effects of curcumin on sepsis and mechanisms of action: A systematic review of preclinical studies.姜黄素对脓毒症的治疗作用及其作用机制:临床前研究的系统评价。
Phytother Res. 2019 Nov;33(11):2798-2820. doi: 10.1002/ptr.6467. Epub 2019 Aug 19.
8
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?姜黄素纳米系统会成为新冠治疗试验中下一个有前景的抗病毒替代方案吗?
Biomed Pharmacother. 2021 Jul;139:111578. doi: 10.1016/j.biopha.2021.111578. Epub 2021 Apr 6.
9
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.姜黄素通过抑制细胞结合来抑制寨卡病毒和基孔肯雅病毒感染。
Antiviral Res. 2017 Jun;142:148-157. doi: 10.1016/j.antiviral.2017.03.014. Epub 2017 Mar 24.
10
Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line.姜黄素衍生物在Vero细胞系中对单纯疱疹病毒1型的抗病毒活性评估。
Nat Prod Commun. 2010 Dec;5(12):1935-8.

引用本文的文献

1
Membrane-Targeting Antivirals.膜靶向抗病毒药物。
Int J Mol Sci. 2025 Jul 28;26(15):7276. doi: 10.3390/ijms26157276.
2
A review of herbal therapeutics for the prevention and management of poxvirus infections.用于预防和治疗痘病毒感染的草药疗法综述。
Arch Microbiol. 2025 Jun 25;207(8):186. doi: 10.1007/s00203-025-04367-3.
3
Potential Benefits of In Silico Methods: A Promising Alternative in Natural Compound's Drug Discovery and Repurposing for HBV Therapy.计算机模拟方法的潜在益处:在天然化合物用于乙肝治疗的药物发现和重新利用方面的一种有前景的替代方法。

本文引用的文献

1
Curcumin inhibited hepatitis B viral entry through NTCP binding.姜黄素通过与 NTCP 结合抑制乙型肝炎病毒进入。
Sci Rep. 2021 Sep 27;11(1):19125. doi: 10.1038/s41598-021-98243-x.
2
Curcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation.姜黄素通过影响病毒包涵体形成抑制人类副流感病毒 3 型的复制。
Biomed Res Int. 2021 Aug 9;2021:1807293. doi: 10.1155/2021/1807293. eCollection 2021.
3
Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
Pharmaceuticals (Basel). 2025 Mar 16;18(3):419. doi: 10.3390/ph18030419.
4
Structure-based drug designing for potential antiviral activity of selected natural product against Monkeypox (Mpox) virus and its host targets.基于结构的药物设计,以研究选定天然产物对猴痘(Mpox)病毒及其宿主靶点的潜在抗病毒活性。
Virusdisease. 2024 Dec;35(4):589-608. doi: 10.1007/s13337-024-00900-y. Epub 2024 Nov 29.
5
New Perspectives about Relevant Natural Compounds for Current Dentistry Research.当前牙科研究中相关天然化合物的新视角。
Life (Basel). 2024 Jul 29;14(8):951. doi: 10.3390/life14080951.
6
Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K/AKT/NF-κB signalling pathway.姜黄素通过抑制 PI3K/AKT/NF-κB 信号通路抑制中性粒细胞迁移来减轻狼疮肾炎。
Lupus Sci Med. 2024 Jul 24;11(2):e001220. doi: 10.1136/lupus-2024-001220.
7
Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.用于克服姜黄素制剂挑战的纳米载体系统研究进展:当前见解
Nanomaterials (Basel). 2024 Apr 12;14(8):672. doi: 10.3390/nano14080672.
8
Entry inhibitors as arenavirus antivirals.作为沙粒病毒抗病毒药物的进入抑制剂。
Front Microbiol. 2024 Apr 8;15:1382953. doi: 10.3389/fmicb.2024.1382953. eCollection 2024.
9
Promising Potential of Curcumin and Related Compounds for Antiviral Drug Discovery.姜黄素和相关化合物在抗病毒药物发现方面的广阔前景。
Med Chem. 2024;20(6):597-612. doi: 10.2174/0115734064277371240325105016.
10
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis.姜黄素作为COVID-19中的抗病毒剂和免疫炎症调节剂:一项科学计量学分析。
Heliyon. 2023 Nov 2;9(11):e21648. doi: 10.1016/j.heliyon.2023.e21648. eCollection 2023 Nov.
伊朗对 SARS-CoV-2 毒株的研究表明,不同毒株的合并感染和重组可能有助于新毒株的出现。
Virology. 2021 Oct;562:63-73. doi: 10.1016/j.virol.2021.06.004. Epub 2021 Jun 19.
4
Activity of phytochemical constituents of (turmeric) and against coronavirus (COVID-19): an in silico approach.姜黄和[未提及的物质]的植物化学成分对冠状病毒(COVID-19)的活性:一种计算机模拟方法。
Futur J Pharm Sci. 2020;6(1):104. doi: 10.1186/s43094-020-00126-x. Epub 2020 Oct 16.
5
Antiviral Effects of Curcumin on Adenovirus Replication.姜黄素对腺病毒复制的抗病毒作用。
Microorganisms. 2020 Oct 4;8(10):1524. doi: 10.3390/microorganisms8101524.
6
Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.鉴定可与冠状病毒(SARS-CoV-2)Nsp15 蛋白靶标结合的植物化学物质作为有潜力的治疗药物,这些物质能够抑制病毒复制。
Phytomedicine. 2021 May;85:153317. doi: 10.1016/j.phymed.2020.153317. Epub 2020 Sep 3.
7
Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus .姜黄素对传染性胃肠炎病毒的抗病毒和杀病毒作用。
J Gen Virol. 2020 Oct;101(10):1079-1084. doi: 10.1099/jgv.0.001466. Epub 2020 Jul 16.
8
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.基于结构的药物设计,用于研究阿育吠陀中选定天然产物对SARS-CoV-2刺突糖蛋白及其细胞受体的潜在抗病毒活性。
Virusdisease. 2020 Jun;31(2):179-193. doi: 10.1007/s13337-020-00598-8. Epub 2020 May 24.
9
Potential effects of curcumin in the treatment of COVID-19 infection.姜黄素治疗 COVID-19 感染的潜在作用。
Phytother Res. 2020 Nov;34(11):2911-2920. doi: 10.1002/ptr.6738. Epub 2020 Jun 23.
10
3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.3D 定量构效关系及姜黄素衍生物抗流感 H1N1 神经氨酸酶活性的研究
Arch Pharm Res. 2020 May;43(5):489-502. doi: 10.1007/s12272-020-01230-5. Epub 2020 Apr 4.